WHO ICTRP trial
A prospective, randomized, controlled study of the efficacy and safety of Fufang…
ChiCTR1900024240 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR1900024240 |
|---|---|
| Public title | A prospective, randomized, controlled study of the efficacy and safety of Fufang Banmao Capsule for treating advanced non-small cell lung cancer after EGFR-TKI therapy |
| Scientific title | A prospective, randomized, controlled study of the efficacy and safety of Fufang Banmao Capsule for treating advanced non-small cell lung cancer after EGFR-TKI therapy |
| Primary sponsor | Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | NSCLC |
| Interventions | experimental group:Compound cantharidin capsule combined with EGFR-TKI;control group:EGFR-TKI |
| Registration date | Jul 2, 2019 |
| Target size | experimental group:60;control group:60 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: